Sign in
TIVC Stock Price, Chart, Stats & News
Tivic Health Systems, Inc.
Save
Tivic Health Systems, Inc. (TIVC) does not currently pay a dividend.
586,042
Market cap
–
Current P/E
–
Forward P/E
TIVC chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -58.09% |
Operating margin | -1548.96% |
Pretax margin | -1557.26% |
Net margin | -1557.26% |
Effective tax rate | – |
ROA | -120.50% |
ROE | -202.20% |
D/E | – |
Interest coverage ratio | – |
TIVC valuation
P/E | – |
P/S | 2.09x |
P/B | 0.22x |
P/CF | -0.20x |
P/FCF | -0.16x |
P/OCF | -0.20x |
PEG | -0.01x |
EV multiple | -0.61x |
About
Tivic Health Systems, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company’s pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications.
Similar securities
Based on sector and market capitalization
Report issue